John Bicket, 10% Owner, Director, Executive Vice President, Chief Technology Officer, on May 12, 2026, sold 263,900 shares in Samsara (IOT) for $7,436,747. Following the Form 4 filing with the SEC, Bicket has control over a total of 619,711 Class A common shares of the company, with 552,111 shares held directly and 67,600 controlled indirectly.
SEC Filing:
Antonio J Viana, Director, on May 13, 2026, sold 40,000 shares in Arteris (AIP) for $1,446,963. Following the Form 4 filing with the SEC, Viana has control over a total of 85,460 common shares of the company, with 20,840 shares held directly and 64,620 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1667011/000188868626000004/xslF345X05/primarydocument.xml
Martine A Rothblatt, Director, Chairperson & CEO, on May 13, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,497,166. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000053/xslF345X05/primarydocument.xml
Sanjit Biswas, 10% Owner, Director, and CEO, on April 02, 2026, sold 263,900 shares in Samsara (IOT) for $7,436,695. Following the Form 4 filing with the SEC, Biswas has control over a total of 67,600 Class A common shares of the company, with 67,600 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1642896/000189511126000009/xslF345X05/form4-05142026_090537.xml